cytokine-based CD8 Treg network modulator (Mozart Therapeutics)

N/A

Report date: 2025/06/11 11:07:26

Base Information

Drug Namecytokine-based CD8 Treg network modulator (Mozart Therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCytokines modulatorsCluster of differentiation 8 modulatorsRegulatory T-lymphocytes modulators +[4] 
TargetsCytokinesCluster of differentiation 8
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMozart Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMozart Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A